pharma · COVID-19 · Poliomyelitis
Sinovac Research and
Sinovac Research and Development Co.,
Sinovac Research and clinical programs — 18 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Dhaka, CN
- Founded
- 2022
- Employees
- 9
- Programs
- 115
- Drugs
- 54
- Patents
- 0
Sinovac Research and projects
18 ClinicalTrials.gov programs sponsored by Sinovac Research and.
Sinovac Research and has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
100U EV71 vaccine with adjuvant
Sinovac Research and Development Co.,
Infection, Viral, Enterovirus
1 trial -
400 U EV71 vaccine with adjuvant
Sinovac Research and Development Co.,
Infection, Viral, Enterovirus
1 trial -
CoronaVac®
Sinovac Research and Development Co.,
COVID-19
1 trial -
Low-dose experimental vaccine
Sinovac Research and Development Co.,
Herpes Zoster
1 trial -
Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)
Sinovac Research and Development Co.,
Hand, Foot, and Mouth Disease (HFMD)
1 trial -
Oral hexavalent reassortant rotavirus attenuated live vaccine
Sinovac Research and Development Co.,
Rotavirus Gastroenteritis
2 trials -
PRO-EV71/CA16-1001
Sinovac Research and Development Co.,
Hand, Foot and Mouth Disease
1 trial -
PRO-nCOV-1002
Sinovac Research and Development Co.,
COVID-19
2 trials -
PRO-nCOV-1003
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-2002
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-2004
Sinovac Research and Development Co.,
COVID-19
1 trial -
PRO-nCOV-2009
Sinovac Research and Development Co.,
COVID-19
1 trial -
SA55 Injection
Sinovac Research and Development Co.,
Infection of Upper Respiratory Tract Caused by 2019-nCoV
1 trial -
SNA02-48
Sinovac Research and Development Co.,
Tetanus
1 trial -
Single-dose regimen of high dosage investigational sIPV
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
Sinovac Low-dosage PCV24
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
1 trial -
Sinovac PCV24
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
2 trials -
pandemic influenza vaccine (H5N1 strain NIBRG-14)
Sinovac Research and Development Co.,
Pandemic Influenza
1 trial
Frequently asked questions
How many clinical projects does Sinovac Research and have?
18 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.